Susquehanna Fundamental Investments, LLC Sarepta Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$106.4 - $157.19 $1.7 Million - $2.52 Million	-16,001 Reduced 19.66%	65,382 $7.49 Million
Q1 2023 May 16, 2023	SELL	$117.53 - $155.99 $537,347 - $713,186	-4,572 Reduced 5.32%	81,383 $11.2 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $1.36 Million - $1.79 Million	-13,522 Reduced 13.59%	85,955 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $3.61 Million - $5.68 Million	47,617 Added 91.82%	99,477 $11 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $180,040 - $257,787	2,851 Added 5.82%	51,860 $4.05 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $363,216 - $467,274	4,700 Added 10.61%	49,009 $4.41 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $2.92 Million - $4.1 Million	44,309 New	44,309 $4.1 Million
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $2.35 Million - $2.93 Million	-33,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $2.44 Million - $5.71 Million	33,800 New	33,800 $2.52 Million

535

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.